About Neurenati
Neurenati is a company based in Montreal (Canada) founded in 2020.. Neurenati has raised $2.9 million across 2 funding rounds from investors including Invest Quebec. Neurenati offers products and services including NEU-001. Neurenati operates in a competitive market with competitors including AllStripes, Zenas BioPharma, Prime Global, CTI Clinical Trial and Atlantic Research Group, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurenati Therapeutics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.9 M (USD)
in 2 rounds
-
Latest Funding Round
$1.7 M (USD), Seed
Apr 18, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurenati
Neurenati offers a comprehensive portfolio of products and services, including NEU-001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enema-based treatment to regenerate enteric nervous system for Hirschsprung's disease.
Unlock access to complete
Unlock access to complete
Funding Insights of Neurenati
Neurenati has successfully raised a total of $2.9M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.7 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.7M
-
First Round
First Round
(29 Feb 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Seed - Neurenati | Valuation |
investors |
|
| Feb, 2024 | Amount | Seed - Neurenati | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neurenati
Neurenati has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Invest Quebec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business guidance for corporate companies and startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurenati
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neurenati
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurenati Comparisons
Competitors of Neurenati
Neurenati operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AllStripes, Zenas BioPharma, Prime Global, CTI Clinical Trial and Atlantic Research Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of information to patients and communities with the medical data for rare diseases
|
|
| domain | founded_year | HQ Location |
Clinical development services for autoimmune and rare diseases are provided.
|
|
| domain | founded_year | HQ Location |
Medical communication solutions are provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Provides clinical trials, consulting, and regulatory services in healthcare sectors.
|
|
| domain | founded_year | HQ Location |
Contract Research Organization for clinical trials in oncology, immunology, and neurology sectors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurenati
Frequently Asked Questions about Neurenati
When was Neurenati founded?
Neurenati was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Where is Neurenati located?
Neurenati is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Who is the current CEO of Neurenati?
Maxime Ranger is the current CEO of Neurenati.
Is Neurenati a funded company?
Neurenati is a funded company, having raised a total of $2.9M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Feb 29, 2024.
What does Neurenati do?
Neurenati Therapeutics was founded in 2020 in Montreal, Canada, as a biotech firm targeting rare diseases. Development efforts are centered on Hirschsprung disease through the NEU-001 therapy. A 1.2 million seed financing round was recently completed to support advancement of this program. Leadership is provided by CEO Maxime Ranger, experienced in life sciences entrepreneurship and venture capital. Operations remain based in the Canadian biotech sector.
Who are the top competitors of Neurenati?
Neurenati's top competitors include Zenas BioPharma, AllStripes and Prime Global.
What products or services does Neurenati offer?
Neurenati offers NEU-001.
Who are Neurenati's investors?
Neurenati has 1 investor. Key investors include Invest Quebec.